FDA would require notice of food additives; RFK Jr. touts GRAS reform, with nutrition advocates split on the proposal.
Small CRISPR startup scrapped plans despite some FDA flexibility, highlighting ongoing regulatory hurdles for niche gene-editing ventures.
Open-source diabetes software outside FDA oversight reportedly improves glucose control and is free/on iPhone, but regulatory risk grows as updates outpace FDA review.
Oura Ring is lobbying in Washington to relax wearable regulation, signaling a push to ease regulatory constraints on health-tracking devices.
Subscribe for real-time topic updates and unlimited access to our intelligence platform.